Presentation
7 March 2022 Label-free clinical metabolic and biochemical imaging of the oral epithelial cancer enabled by autofluorescence lifetime imaging endoscopy
Author Affiliations +
Abstract
Increased cellular metabolic activity can be quantified by imaging the oral tissue autofluorescence originated from NADH and FAD. Clinical label-free metabolic imaging of oral epithelial cancer based on 375-nm excitation maFLIM endoscopy was recently demonstrated in patients presenting oral malignant lesions. A recently upgraded maFLIM endoscopy system enables simultaneous autofluorescence excitation at 375 nm (for NADH) and 445 nm (for FAD). This maFLIM endoscope is being used to clinically image healthy, benign, precancerous and cancerous oral lesions in oral health care settings. Comprehensive statistical analysis will be performed to identify new metabolic and biochemical autofluorescence biomarkers of oral epithelial cancer.
Conference Presentation
© (2022) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Rodrigo Cuenca Martinez, Michael J. Serafino, Gabriel P. Tortorelli, Sharukh S. Khajotia, Ronald C. Faram, David M. Lewis, Lida Radfar, Kathleen E. Higgins, Yi-Shing L. Cheng, and Javier A. Jo "Label-free clinical metabolic and biochemical imaging of the oral epithelial cancer enabled by autofluorescence lifetime imaging endoscopy", Proc. SPIE PC11935, Imaging, Therapeutics, and Advanced Technology in Head and Neck Surgery and Otolaryngology 2022, PC1193509 (7 March 2022); https://doi.org/10.1117/12.2609017
Advertisement
Advertisement
KEYWORDS
Endoscopy

Cancer

Luminescence

Multispectral imaging

Medicine

Proteins

Statistical analysis

Back to Top